Allergy Therapeutics PLC

LSE:AGY (UK)  
£ 0.05 (-2.86%) Jun 18
At Loss
P/B:
8.50
Market Cap:
£ 243.09M ($ 309.17M)
Enterprise V:
£ 239.42M ($ 304.50M)
Volume:
1.15M
Avg Vol (2M):
1.08M
Trade In:
Volume:
1.15M
At Loss
Avg Vol (2M):
1.08M

Business Description

Description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 1.37
Equity-to-Asset 0.38
Debt-to-Equity 0.37
Debt-to-EBITDA -0.25
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.86
Distress
Grey
Safe
Beneish M-Score -4.04
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -8.5
3-Year Book Growth Rate -64.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 43.15
9-Day RSI 57.96
14-Day RSI 63.79
6-1 Month Momentum % 45.09
12-1 Month Momentum % -48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.4
Quick Ratio 0.93
Cash Ratio 0.54
Days Inventory 165.86
Days Sales Outstanding 54.82
Days Payable 185.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.6
Shareholder Yield % -20.98

Financials (Next Earnings Date:2024-09-27 Est.)

LSE:AGY's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Allergy Therapeutics PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 53.258
EPS (TTM) (£) -0.057
Beta 1.51
Volatility % 220.24
14-Day RSI 63.79
14-Day ATR (£) 0.004518
20-Day SMA (£) 0.046453
12-1 Month Momentum % -48
52-Week Range (£) 0.008 - 0.063
Shares Outstanding (Mil) 4,766.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Allergy Therapeutics PLC Filings

Filing Date Document Date Form
No Filing Data

Allergy Therapeutics PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

Allergy Therapeutics PLC Frequently Asked Questions

What is Allergy Therapeutics PLC(LSE:AGY)'s stock price today?
The current price of LSE:AGY is £0.05. The 52 week high of LSE:AGY is £0.06 and 52 week low is £0.01.
When is next earnings date of Allergy Therapeutics PLC(LSE:AGY)?
The next earnings date of Allergy Therapeutics PLC(LSE:AGY) is 2024-09-27 Est..
Does Allergy Therapeutics PLC(LSE:AGY) pay dividends? If so, how much?
Allergy Therapeutics PLC(LSE:AGY) does not pay dividend.

Press Release

Subject Date
No Press Release